Quick Answer
ADMA BIOLOGICS, INC. reported Cash And Cash Equivalents At Carrying Value of $87.63 million for the year ending 2025.
- ADMA BIOLOGICS, INC. showed a decrease of -15.0% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from ADMA BIOLOGICS, INC.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), ADMA BIOLOGICS, INC.'s Cash And Cash Equivalents At Carrying Value has grown by 38,171.2%.
- Historical annual values: Fiscal year 2025: $87.63 million | Fiscal year 2024: $103.15 million | Fiscal year 2023: $51.35 million | Fiscal year 2022: $86.52 million | Fiscal year 2021: $51.09 million | Fiscal year 2020: $55.92 million | Fiscal year 2019: $26.75 million | Fiscal year 2018: $26.75 million | Fiscal year 2017: $43.11 million | Fiscal year 2016: $9.91 million | Fiscal year 2015: $10.44 million | Fiscal year 2014: $17.20 million | Fiscal year 2013: $26.15 million | Fiscal year 2012: $12.54 million | Fiscal year 2011: $87.8 thousand | Fiscal year 2010: $229.0 thousand.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: